MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 17, 2015, Pages 3208-3217

  Li, Z B ^a   Li, Z Z ^b   Li, L ^a   Chu, H T ^a   Jia, M ^a  

^a Department of Internal Medicine Zaozhuang Municipal Hospital   (China)

^b Shizhong District People's Hospital of Zaozhuang City   (China)

Author keywords

HCC; IR 183; MiR 21; SOCS6.

Indexed keywords

CASPASE 3; CASPASE 7; MICRORNA; MICRORNA 183; MICRORNA 21; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 6; UNCLASSIFIED DRUG; SOCS6 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL LINE; CANCER GROWTH; CARCINOMA CELL LINE; CELL VIABILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HEP3B CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; AGED; CELL PROLIFERATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY;

AGED; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFECTION;

EID: 84973420365     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. NGUYEN LH, NGUYEN MH. Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther 2013; 37: 921-936.
2. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 014. CA Cancer J Clin 2014; 64: 9-29.
3. MORISE Z, KAWABE N, TOMISHIGE H, NAGATA H, KAWASE J, ARAKAWA S, YOSHIDA R, ISETANI M. Recent ad-vances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol 2014; 20: 14381-14392.
4. RAHBARI NN, MEHRABI A, MOLLBERG NM, MULLER SA, KOCH M, BUCHLER MW, WEITZ J. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011; 253: 453-469.
5. ZHAO FT, ZHOU Y, ZHOU YX, YANG Q, SONG L, JIANG XJ, JIA ZS. Competitive Binding between miR-122 and p68 onto Hepatitis C Viral RNA. Med Sci Monit 2015; 21: 980-986.
6. XIE D, SHANG C, ZHANG H, GUO Y, TONG X. Up-regulation of miR-9 target CBX7 to regulate invasion ability of bladder transitional cell carcinoma. Med Sci Monit 2015; 21: 225-230.
7. LIU Y, DING Y, HUANG J, WANG S, NI W, GUAN J, LI Q, ZHANG Y, DING Y, CHEN B, CHEN L. MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1. PLoS One 2014; 9: e88393.
8. WU SM, AI HW, ZHANG DY, HAN XQ, PAN Q, LUO FL, ZHANG XL. MiR-141 targets ZEB2 to suppress HCC progression. Tumour Biol 2014; 35: 9993-9997.
9. XUE J, NIU YF, HUANG J, PENG G, WANG LX, YANG YH, LI YQ. miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3. Tumour Biol 2014; 35: 12103-12107.
10. MA Y, SHE XG, MING YZ, WAN QQ. miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7. Tumour Biol 2014; 35: 10731-10736.
11. CHUANG KH, WHITNEY-MILLER CL, CHU CY, ZHOU Z, DOKUS MK, SCHMIT S, BARRY CT. MicroRNA-494 is a master epigenetic regulator of multiple invasionsuppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors. Hepatology 2015; 62: 466-480.
12. ZHU Q, WANG Z, HU Y, LI J, LI X, ZHOU L, HUANG Y. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 2012; 27: 1660-1668.
13. WANG WY, ZHANG HF, WANG L, MA YP, GAO F, ZHANG SJ, WANG LC. miR-21 expression predicts prognosis in hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2014; 38: 715-719.
14. WANG Y, GAO X, WEI F, ZHANG X, YU J, ZHAO H, SUN Q, YAN F, YAN C, LI H, REN X. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. Gene 2014; 533: 389-397.
15. LIU AM, YAO TJ, WANG W, WONG KF, LEE NP, FAN ST, POON RT, GAO C, LUK JM. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open 2012; 2: e000825.
16. LI J, FU H, XU C, TIE Y, XING R, ZHU J, QIN Y, SUN Z, ZHENG X. miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 2010; 10: 354.
17. LEUNG WK, HE M, CHAN AW, LAW PT, WONG N. Wnt/beta-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion. Cancer Lett 2015; 362: 97-105.
18. KABIR NN, SUN J, RONNSTRAND L, KAZI JU. SOCS6 is a selective suppressor of receptor tyrosine kinase signaling. Tumour Biol 2014; 35: 10581-10589.
19. GE W, YU DC, LI QG, CHEN X, ZHANG CY, DING YT. Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances. Clin Lab 2014; 60: 427-434.
20. QIU X, DONG S, QIAO F, LU S, SONG Y, LAO Y, LI Y, ZENG T, HU J, ZHANG L, ZHANG L, FAN H. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 2013; 32: 3296-3305.
21. WOJCICKA A, SWIERNIAK M, KORNASIEWICZ O, GIER-LIKOWSKI W, MACIAG M, KOLANOWSKA M, KOTLAREK M, GORNICKA B, KOPERSKI L, NIEWINSKI G, KRAWCZYK M, JAZDZEWSKI K. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma. Int J Biochem Cell Biol 2014; 53: 208-217.
22. KARAKATSANIS A, PAPACONSTANTINOU I, GAZOULI M, LY-BEROPOULOU A, POLYMENEAS G, VOROS D. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 2013; 52: 297-303.
23. ZHANG QH, SUN HM, ZHENG RZ, LI YC, ZHANG Q, CHENG P, TANG ZH, HUANG F. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene 2013; 527: 26-32.
24. LIANG Z, GAO Y, SHI W, ZHAI D, LI S, JING L, GUO H, LIU T, WANG Y, DU Z. Expression and significance of microRNA-183 in hepatocellular carcinoma. Scientific World J 2013; 2013: 381874.
25. DONG M, YANG P, HUA F. miR-191 Modulates Malignant Transformation of Endometriosis Through Regulating TIMP3. Med Sci Monit 2015; 21: 915-920.
26. LEI W, LIU YE, ZHENG Y, QU L. MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1. Med Sci Monit 2015; 21: 383-389.
27. LEI Y. HU X, LI B, PENG M, TONG S, ZU X, WANG Z, QI L, CHEN M. miR-150 modulates cisplatin chemosensitivity and invasiveness of muscle-invasive bladder cancer cells via targeting PDCD4 in vitro. Med Sci Monit 2014; 20: 1850-1857.
28. SHANG C, HONG Y, GUO Y, LIU YH, XUE YX. MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A. Med Sci Monit 2014; 20: 2571-2577.
29. WAGENAAR TR, ZABLUDOFF S, AHN SM, ALLERSON C, ARLT H, BAFFA R, CAO H, DAVIS S, GARCIA-ECHEVERRIA C, GAUR R, HUANG SM, JIANG L, KIM D, METZ-WEID-MANN C, PAVLICEK A, POLLARD J, REEVES J, ROCNIK JL, CHEIDLER S, SHI C, SUN F, TOLSTYKH T, WEBER W, WIN-TER C, YU E, YU Q, ZHENG G, WIEDERSCHAIN D. AntimiR-21 suppresses hepatocellular carcinoma growth via broad transcriptional network deregulation. Mol Cancer Res 2015; 13: 1009-1021.
30. CHEN M, LIU Y, VARLEY P, CHANG Y, HE XX, HUANG H, TANG D, LOTZE MT, LIN J, TSUNG A. High-mobility group box 1 promotes hepatocellular carcinoma progression through miR-21-mediated matrix metalloproteinase activity. Cancer Res 2015; 75: 1645-1656.
31. QIU X, ZHENG J, GUO X, GAO X, LIU H, TU Y, ZHANG Y. Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis. Mol Cell Biochem 2013; 378: 99-106.
32. LIN HY, LAI RH, LIN ST, LIN RC, WANG MJ, LIN CC, LEE HC, WANG FF, CHEN JY. Suppressor of cytokine signaling 6 (SOCS6 promotes mitochondrial fission via regulating DRP1 translocation. Cell Death Differ 2013; 20: 139-153.
33. KAZI JU, SUN J, PHUNG B, ZADJALI F, FLORES-MORALES A, RONNSTRAND L. Suppressor of cytokine signaling 6 (SOCS6 negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3. J Biol Chem 2012; 287: 36509-36517.
34. WU K, HU G, HE X, ZHOU P, LI J, HE B, SUN W. MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. Pathol Oncol Res 2013; 19: 739-748.
35. TANAKA T, ARAI M, JIANG X, SUGAYA S, KANDA T, FUJII K, KITA K, SUGITA K, IMAZEKI F, MIYASHITA T, KANEDA A, YOKOSUKA O. Downregulation of microRNA-431 by human interferon-beta inhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6. Int J Oncol 2014; 44: 1685-1690.
36. WU Q, LUO G, YANG Z, ZHU F, AN Y, SHI Y, FAN D. miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells. FEBS Lett 2014; 588: 2055-2062.